148 related articles for article (PubMed ID: 18084760)
1. Biochemical markers of bone turnover in aseptic loosening in hip arthroplasty.
Streich NA; Gotterbarm T; Jung M; Schneider U; Heisel C
Int Orthop; 2009 Feb; 33(1):77-82. PubMed ID: 18084760
[TBL] [Abstract][Full Text] [Related]
2. Increased urinary crosslink levels in aseptic loosening of total hip arthroplasty.
Schneider U; Breusch SJ; Termath S; Thomsen M; Brocai DR; Niethard FU; Kasperk C
J Arthroplasty; 1998 Sep; 13(6):687-92. PubMed ID: 9741447
[TBL] [Abstract][Full Text] [Related]
3. [Urinary concentration of collagen metabolites in endoprosthesis loosening].
Witzleb WC; Menschikowski M
Z Orthop Ihre Grenzgeb; 2001; 139(3):240-4. PubMed ID: 11486627
[TBL] [Abstract][Full Text] [Related]
4. [Use of new biochemical markers in diagnosis of aseptic hip endoprosthesis loosening].
Schneider U; Termath S; Thomsen M; Brocai DR; Niethard FU
Z Orthop Ihre Grenzgeb; 1997; 135(4):297-300. PubMed ID: 9381765
[TBL] [Abstract][Full Text] [Related]
5. Effects upon bone metabolism following total hip and total knee arthroplasty.
Schneider U; Schmidt-Rohlfing B; Knopf U; Breusch SJ
Pathobiology; 2002; 70(1):26-33. PubMed ID: 12415189
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density and biochemical markers of bone turnover in aseptic loosening after total hip arthroplasty.
Wilkinson JM; Hamer AJ; Rogers A; Stockley I; Eastell R
J Orthop Res; 2003 Jul; 21(4):691-6. PubMed ID: 12798070
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of bone turnover markers as a screening tool for aseptic loosening after total hip arthroplasty.
Lawrence NR; Jayasuriya RL; Gossiel F; Wilkinson JM
Hip Int; 2015; 25(6):525-30. PubMed ID: 26044531
[TBL] [Abstract][Full Text] [Related]
8. Change of cross-linked telopeptide of type I collagen (ICTP) and other bone resorption markers in patients with bone fragility fractures.
Takahara K; Kamimura M; Hashidate H; Uchiyama S; Nakagawa H
J Orthop Sci; 2007 May; 12(3):219-26. PubMed ID: 17530373
[TBL] [Abstract][Full Text] [Related]
9. Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetes.
Fassbender WJ; Gödde M; Brandenburg VM; Usadel KH; Stumpf UC
Adv Med Sci; 2009; 54(1):1-6. PubMed ID: 19482729
[TBL] [Abstract][Full Text] [Related]
10. Correlations between biochemical markers of bone resorption and creatinine excretion.
Green JH
Scand J Clin Lab Invest; 2001 Feb; 61(1):27-32. PubMed ID: 11300608
[TBL] [Abstract][Full Text] [Related]
11. New biochemical markers of bone resorption in the study of postmenopausal osteoporosis.
de la Piedra C; Traba ML; Dominguez Cabrera C; Sosa Henríquez M
Clin Chim Acta; 1997 Sep; 265(2):225-34. PubMed ID: 9385464
[TBL] [Abstract][Full Text] [Related]
12. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.
Garnero P; Hausherr E; Chapuy MC; Marcelli C; Grandjean H; Muller C; Cormier C; Bréart G; Meunier PJ; Delmas PD
J Bone Miner Res; 1996 Oct; 11(10):1531-8. PubMed ID: 8889854
[TBL] [Abstract][Full Text] [Related]
13. Tartrate-resistant acid phosphatase 5b and C-terminal telopeptides of type I collagen as markers for diagnosis of aseptic loosening after total hip replacement.
Landgraeber S; Löer F; Heep H; Classen T; Grabellus F; Totsch M; von Knoch M
Arch Orthop Trauma Surg; 2010 Apr; 130(4):441-5. PubMed ID: 19513735
[TBL] [Abstract][Full Text] [Related]
14. The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women.
Chaki O; Yoshikata I; Kikuchi R; Nakayama M; Uchiyama Y; Hirahara F; Gorai I
J Bone Miner Res; 2000 Aug; 15(8):1537-44. PubMed ID: 10934652
[TBL] [Abstract][Full Text] [Related]
15. Urinary creatinine instability falsely increases the deoxypyridinoline/creatinine quotient.
Schneider U; Schober EA; Streich NA; Breusch SJ
Clin Chim Acta; 2002 Oct; 324(1-2):81-88. PubMed ID: 12204428
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of urinary pyridinium crosslinks and their derivatives in multiple myeloma.
Samani KK; Brazier M; Mathiot C; Kamel S; Jamart J; Jaubert J; Blanc M; Azaïs I; Facon T; Leleu X
Ann Hematol; 2005 Jan; 84(1):19-24. PubMed ID: 15338198
[TBL] [Abstract][Full Text] [Related]
17. The value of desoxypyridinoline in the diagnostics of loosened arthroplasty.
Pellengahr C; Mayer W; Dürr HR; Maier M; Müller P; Veihelmann A; Zysk S; Jansson V; Refior HJ
Arch Orthop Trauma Surg; 2001; 121(4):205-6. PubMed ID: 11317681
[TBL] [Abstract][Full Text] [Related]
18. Variability in urinary excretion of bone resorption markers: limitations of a single determination in clinical practice.
Borderie D; Roux C; Toussaint B; Dougados M; Ekindjian OG; Cherruau B
Clin Biochem; 2001 Oct; 34(7):571-7. PubMed ID: 11738394
[TBL] [Abstract][Full Text] [Related]
19. Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices.
Woitge HW; Pecherstorfer M; Li Y; Keck AV; Horn E; Ziegler R; Seibel MJ
J Bone Miner Res; 1999 May; 14(5):792-801. PubMed ID: 10320528
[TBL] [Abstract][Full Text] [Related]
20. Systemic cross-linked N-terminal telopeptide and procollagen I C-terminal extension peptide as markers of bone turnover after total hip arthroplasty.
Savarino L; Granchi D; Cenni E; Baldini N; Greco M; Giunti A
J Bone Joint Surg Br; 2005 Apr; 87(4):571-6. PubMed ID: 15795214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
